Study results show radiotherapy in fewer but larger doses is safe for early breast cancer

According to findings of the FAST trial, five larger radiotherapy doses after surgery, once-a-week sessions for five weeks instead of daily radiotherapy over the same time, totalling 25 doses, cause similarly low rates of side-effects in women with early-stage breast cancer in the long run. Fewer treatment sessions would particularly benefit patients at low risk

Continue Reading

NHS launches new online support for diabetes management

NHS England has launched new online services allowing those with diabetes to better manage their condition remotely during the coronavirus pandemic. A range of online videos and training will be available for children and adults, which will include advice on treatment and care and adopting healthy behaviours on diet and exercise, complementing video consultations with

Continue Reading

GSK partners with Clover Biopharmaceuticals to assist with Coronavirus

GSK has recruited China-based Clover Biopharmaceuticals, to help develop its protein-based coronavirus vaccine candidate (COVID-19 S-Trimer). Under the new agreement, GSK says it will provide Clover with its pandemic adjuvant system for further evaluation of S-Trimer in preclinical studies, in hopes that Clover could potentially rapidly scale-up and produce large-quantities of a new coronavirus vaccine.

Continue Reading

NHS Scotland to fund new therapies for AML, Arthritis and others

The Scottish Medicines Consortium has endorsed NHS funding for four therapies that  new treatment options for acute myeloid leukaemia, Still’s disease, adrenal insufficiency and psoriatic arthritis. Pfizer’s Gemtuzumab ozogamicin was accepted for the treatment of acute myeloid leukaemia (AML), after being considered through the SMC’s Patient and Clinician Engagement (PACE) process. Current initial treatment for

Continue Reading